Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome ≥8.2kb

Molecular Therapy

Volumn 18, Issue 1, 2010, Pages 75-79

  Lai, Yi ^a   Yue, Yongping ^a   Duan, Dongsheng ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BETA GALACTOSIDASE; DYSTROPHIN; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA PACKAGING; DUCHENNE MUSCULAR DYSTROPHY; GEL ELECTROPHORESIS; GENE CASSETTE; GENE EXPRESSION; HOMOLOGOUS RECOMBINATION; INVERTED TERMINAL REPEAT; MALE; MOUSE; NONHUMAN; SEROTYPE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRION; VIRUS GENOME; VIRUS PARTICLE;

ALKALINE PHOSPHATASE; ANIMALS; BLOTTING, SOUTHERN; DEPENDOVIRUS; GENE THERAPY; GENETIC VECTORS; GENOME, VIRAL; LAC OPERON; MALE; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCULAR DYSTROPHY, DUCHENNE; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE;

EID: 74149093851     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2009.256     Document Type: Article

References (38)

1. Flotte, TR and Berns, KI (2005). Adeno-associated virus: a ubiquitous commensal of mammals. Hum Gene Ther 16: 401-407.
2. Carter, BJ (2004). Adeno-associated virus and the development of adeno-associated virus vectors: a historical perspective. Mol Ther 10: 981-989.
3. Carter, BJ (2005). Adeno-associated virus vectors in clinical trials. Hum Gene Ther 16: 541-550.
4. Srivastava, A (2008). Adeno-associated virus-mediated gene transfer. J Cell Biochem 105: 17-24.
5. Cideciyan, AV, Hauswirth, WW, Aleman, TS, Kaushal, S, Schwartz, SB, Boye, SL et al. (2009). Vision 1 year after gene therapy for Leber's congenital amaurosis. N Engl J Med 361: 725-727.
6. Bainbridge, JW, Smith, AJ, Barker, SS, Robbie, S, Henderson, R, Balaggan, K et al. (2008). Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 358: 2231-2239.
7. Maguire, AM, Simonelli, F, Pierce, EA, Pugh, EN Jr, Mingozzi, F, Bennicelli, J et al. (2008). Safety and effcacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 358: 2240-2248.
8. Frank, KM, Hogarth, DK, Miller, JL, Mandal, S, Mease, PJ, Samulski, RJ et al. (2009). Investigation of the cause of death in a gene-therapy trial. N Engl J Med 361: 161-169.
9. Duan, D, Yan, Z and Engelhardt, JF (2006). Expanding the capacity of AAV vectors. In: Bloom, ME, SF Cotmore, RM Linden, CR Parrish and JR Kerr (eds). Parvoviruses. Hodder Arnold; Distributed in the U.S.A. by Oxford University Press: London, New York. pp. 525-532.
10. Ghosh, A and Duan, D (2007). Expending adeno-associated viral vector capacity: a tale of two vectors. Biotechnol Genet Eng Rev 24: 165-177.
11. Lai, Y, Yue, Y, Liu, M, Ghosh, A, Engelhardt, JF, Chamberlain, JS et al. (2005). Effcient in vivo gene expression by trans-splicing adeno-associated viral vectors. Nat Biotechnol 23: 1435-1439.
12. Ghosh, A, Yue, Y and Duan, D (2006). Viral serotype and the transgene sequence infuence overlapping adeno-associated viral (AAV) vector-mediated gene transfer in skeletal muscle. J Gene Med 8: 298-305.
13. Ghosh, A, Yue, Y, Lai, Y and Duan, D (2008). A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner. Mol Ther 16: 124-130.
14. Grieger, JC and Samulski, RJ (2005). Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps. J Virol 79: 9933-9944.
15. Warrington, KH Jr, Gorbatyuk, OS, Harrison, JK, Opie, SR, Zolotukhin, S and Muzyczka, N (2004). Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus. J Virol 78: 6595-6609.
16. Lu, H, Chen, L, Wang, J, Huack, B, Sarkar, R, Zhou, S et al. (2008). Complete correction of hemophilia A with adeno-associated viral vectors containing a full-size expression cassette. Hum Gene Ther 19: 648-654.
17. Lai, Y, Thomas, GD, Yue, Y, Yang, HT, Li, D, Long, C et al. (2009). Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J Clin Invest 119: 624-635.
18. Allocca, M, Doria, M, Petrillo, M, Colella, P, Garcia-Hoyos, M, Gibbs, D et al. (2008). Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. J Clin Invest 118: 1955-1964.
19. Duan, D, Yan, Z, Yue, Y, Ding, W and Engelhardt, JF (2001). Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation. J Virol 75: 7662-7671.
20. Duan, D, Sharma, P, Yang, J, Yue, Y, Dudus, L, Zhang, Y et al. (1998). Circular intermediates of recombinant adeno-associated virus have defned structural characteristics responsible for long-term episomal persistence in muscle tissue. J Virol 72: 8568-8577.
21. Walters, RW, Agbandje-McKenna, M, Bowman, VD, Moninger, TO, Olson, NH, Seiler, M et al. (2004). Structure of adeno-associated virus serotype 5. J Virol 78: 3361-3371.
22. Duan, D, Sharma, P, Dudus, L, Zhang, Y, Sanlioglu, S, Yan, Z et al. (1999). Formation of adeno-associated virus circular genomes is differentially regulated by adenovirus E4 ORF6 and E2a gene expression. J Virol 73: 161-169.
23. Carrasco, C, Castellanos, M, de Pablo, PJ and Mateu, MG (2008). Manipulation of the mechanical properties of a virus by protein engineering. Proc Natl Acad Sci USA 105: 4150-4155.
24. Gao, G, Vandenberghe, LH, Alvira, MR, Lu, Y, Calcedo, R, Zhou, X et al. (2004). Clades of Adeno-associated viruses are widely disseminated in human tissues. J Virol 78: 6381-6388.
25. Xu, Z, Yue, Y, Lai, Y, Ye, C, Qiu, J, Pintel, DJ et al. (2004). Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection effciency. Hum Gene Ther 15: 896-905.
26. Wang, XS and Srivastava, A (1997). A novel terminal resolution-like site in the adeno-associated virus type 2 genome. J Virol 71: 1140-1146.
27. Wang, XS, Ponnazhagan, S and Srivastava, A (1996). Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions. J Virol 70: 1668-1677.
28. Wang, XS, Qing, K, Ponnazhagan, S and Srivastava, A (1997). Adeno-associated virus type 2 DNA replication in vivo: mutation analyses of the D sequence in viral inverted terminal repeats. J Virol 71: 3077-3082.
29. Halbert, CL, Allen, JM and Miller, AD (2002). Effcient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. Nat Biotechnol 20: 697-701.
30. Duan, D, Yue, Y and Engelhardt, JF (2001). Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison. Mol Ther 4: 383-391.
31. Bell, P, Limberis, M, Gao, G, Wu, D, Bove, MS, Sanmiguel, JC et al. (2005). An optimized protocol for detection of E. coli beta-galactosidase in lung tissue following gene transfer. Histochem Cell Biol 124: 77-85.
32. Dong, B, Nakai, H, and Xiao, W. Characterization of genome integrity for oversized recombinant AAV vector. Mol Ther (in the press).
33. Wu, Z, Yang, H and Colosi, P. Effect of genome size on AAV vector packaging. Mol Ther (in the press).
34. Duan, D, Yue, Y, Yan, Z, Yang, J and Engelhardt, JF (2000). Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J Clin Invest 105: 1573-1587.
35. Yue, Y and Dongsheng, D (2002). Development of multiple cloning site cis-vectors for recombinant adeno-associated virus production. BioTechniques 33: 672, 674, 676-672, 674, 678.
36. Liu, M, Yue, Y, Harper, SQ, Grange, RW, Chamberlain, JS and Duan, D (2005). Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury. Mol Ther 11: 245-256.
37. Yue, Y, Li, Z, Harper, SQ, Davisson, RL, Chamberlain, JS and Duan, D (2003). Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Circulation 108: 1626-1632.
38. McCarty, DM, Monahan, PE and Samulski, RJ (2001). Self-complementary recombinant adeno-associated virus (scAAV) vectors promote effcient transduction independently of DNA synthesis. Gene Ther 8: 1248-1254.